Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
life sciences
national blog main
biotech
clinical trials
deals
startups
investing
national top stories
480 biomedical
aldehyde
aldeyra therapeutics
allergic conjunctivitis
allosteric
arsenal medical
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
beta-thalassemia
bob langer
brace pharma
chronic rhinosinusitis
cleva pharma
covid-19
dacogen
decitabine
dna
drug delivery
drug discovery
drugs
dry eye disease
dupilumab
epigenetics
epizyme
farydak
fda
flagship pioneering
What
new
4
×
therapeutics
4
×
biotech
developing
medicines
step
address
adds
ago
aims
aldeyra
allosteric
approach
based
called
clinic
closer
company
data
debut
debuts
disclosed
disease
drug
drugs
elusive
epigenetic
epigenetics
eye
fda
field
fighting
filing
flagship’s
hotspot
inflammation
ipo
late
lyra
markets
Language
unset
Current search:
therapeutics
×
boston
×
new
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
